{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:09:21Z","timestamp":1790647761130,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Phytecs, Inc","award":["None"],"award-info":[{"award-number":["None"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL139008"],"award-info":[{"award-number":["R01 HL139008"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM080202"],"award-info":[{"award-number":["GM080202"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The cannabis-derived molecules, \u22069 tetrahydrocannabinol (THC) and cannabidiol (CBD), are both of considerable therapeutic interest for a variety of purposes, including to reduce pain and anxiety and increase sleep. In addition to their other pharmacological targets, both THC and CBD are competitive inhibitors of the equilibrative nucleoside transporter-1 (ENT-1), a primary inactivation mechanism for adenosine, and thereby increase adenosine signaling. The goal of this study was to examine the role of adenosine A2A receptor activation in the effects of intraperitoneally administered THC alone and in combination with CBD or PECS-101, a 4\u2032-fluorinated derivative of CBD, in the cannabinoid tetrad, elevated plus maze (EPM) and marble bury assays. Comparisons between wild-type (WT) and A2AR knock out (A2AR-KO) mice were made. The cataleptic effects of THC were diminished in A2AR-KO; no other THC behaviors were affected by A2AR deletion. CBD (5 mg\/kg) potentiated the cataleptic response to THC (5 mg\/kg) in WT but not A2AR-KO. Neither CBD nor THC alone affected EPM behavior; their combination produced a significant increase in open\/closed arm time in WT but not A2AR-KO. Both THC and CBD reduced the number of marbles buried in A2AR-KO but not WT mice. Like CBD, PECS-101 potentiated the cataleptic response to THC in WT but not A2AR-KO mice. PECS-101 also reduced exploratory behavior in the EPM in both genotypes. These results support the hypothesis that CBD and PECS-101 can potentiate the cataleptic effects of THC in a manner consistent with increased endogenous adenosine signaling.<\/jats:p>","DOI":"10.3390\/molecules26175354","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T23:05:12Z","timestamp":1630623912000},"page":"5354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-7406","authenticated-orcid":false,"given":"Todd M.","family":"Stollenwerk","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Pollock","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-748X","authenticated-orcid":false,"given":"Cecilia J.","family":"Hillard","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-030-57369-0_3","article-title":"Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review","volume":"1264","author":"Hallak","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: Pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.euroneuro.2020.01.013","article-title":"Possible therapeutic applications of cannabis in the neuropsychopharmacology field","volume":"36","author":"Sagredo","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/can.2020.0102","article-title":"Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?","volume":"6","author":"Stevenson","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: Relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1874473710666170712113042","article-title":"Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications","volume":"10","author":"Ford","year":"2017","journal-title":"Curr. Drug Abuse Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who Is Who in Adenosine Transport","volume":"9","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"627032","DOI":"10.3389\/fphar.2021.627032","article-title":"The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders","volume":"12","author":"Wydra","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine-cannabinoid receptor interactions. Implications for striatal function","volume":"160","author":"Ferre","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/npp.2017.209","article-title":"Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Delta(9)-Tetrahydrocannabinol","volume":"43","author":"Boggs","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Breuer, A., Haj, C.G., Fogaca, M.V., Gomes, F.V., Silva, N.R., Pedrazzi, J.F., Del Bel, E.A., Hallak, J.C., Crippa, J.A., and Zuardi, A.W. (2016). Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158779"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pnpbp.2017.07.012","article-title":"Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative","volume":"79","author":"Silva","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.1972.tb08092.x","article-title":"A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol","volume":"45","author":"Jones","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Martin, J.L., Gadegbeku, B., Wu, D., Viallon, V., and Laumon, B. (2017). Cannabis, alcohol and fatal road accidents. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187320"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schutz, G., Wotjak, C.T., Lutz, B., and Marsicano, G. (2007). Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol., 5.","DOI":"10.1371\/journal.pbio.0050269"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108287","DOI":"10.1016\/j.neuropharm.2020.108287","article-title":"Differential glutamatergic and GABAergic contributions to the tetrad effects of Delta(9)-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor","volume":"179","author":"Ruehle","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.neuron.2021.03.007","article-title":"Subcellular specificity of cannabinoid effects in striatonigral circuits","volume":"109","author":"Mariani","year":"2021","journal-title":"Neuron"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.npp.1301375","article-title":"Striatal Adenosine A(2A) and Cannabinoid CB(1) Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of Cannabinoids","volume":"32","author":"Carriba","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s12035-018-1456-3","article-title":"Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Delta(9)-Tetrahydrocannabinol-Induced Cognitive Impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00210-002-0613-3","article-title":"Localization of adenosine A2A-receptors in rat brain with [3H]ZM-241385","volume":"366","author":"DeMet","year":"2002","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.WNL.0000095205.33940.99","article-title":"Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function","volume":"61","author":"Rosin","year":"2003","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fncir.2013.00124","article-title":"Spatial distribution of D1R- and D2R-expressing medium-sized spiny neurons differs along the rostro-caudal axis of the mouse dorsal striatum","volume":"7","author":"Gangarossa","year":"2013","journal-title":"Front. Neural Circuits"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1471-4159.2009.06282.x","article-title":"Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum","volume":"110","author":"Tebano","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0304-3940(91)90387-9","article-title":"Stimulation of adenosine A2 receptors induces catalepsy","volume":"130","author":"Ferre","year":"1991","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(97)83039-7","article-title":"Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats","volume":"328","author":"Mandhane","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2019.05.002","article-title":"Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism","volume":"181","author":"Zieba","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Liu, J., Scott, B.W., and Burnham, W.M. (2021). Effects of cannabidiol and Delta9-tetrahydrocannabinol in the elevated plus maze in mice. Behav. Pharmacol.","DOI":"10.1097\/FBP.0000000000000636"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2007.06.025","article-title":"Regulation of DARPP-32 phosphorylation by Delta(9)-tetrahydrocannabinol","volume":"54","author":"Borgkvist","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0149-7634(85)90020-X","article-title":"Basic and clinical aspects of adenosinergic neuromodulation","volume":"9","author":"Marangos","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1073\/pnas.161292398","article-title":"Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor","volume":"98","author":"Johansson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1601-183X.2007.00311.x","article-title":"The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice","volume":"6","author":"Chen","year":"2007","journal-title":"Genes Brain Behav."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.009","article-title":"Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative","volume":"140","author":"Perez","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wydra, K., Gawlinski, D., Gawlinska, K., Frankowska, M., Borroto-Escuela, D.O., Fuxe, K., and Filip, M. (2020). Adenosine A2AReceptors in Substance Use Disorders: A Focus on Cocaine. Cells, 9.","DOI":"10.3390\/cells9061372"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals with Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.2042-7158.1973.tb10024.x","article-title":"An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant","volume":"25","author":"Cradock","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pbb.2014.05.010","article-title":"In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Delta-THC in mice: Inhalation versus intraperitoneal injection","volume":"124C","author":"Marshell","year":"2014","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/17\/5354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:55:23Z","timestamp":1760165723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/17\/5354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":45,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["molecules26175354"],"URL":"https:\/\/doi.org\/10.3390\/molecules26175354","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]}}}